Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Notes Payables (2024 - 2025)

Historic Notes Payables for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to $5.6 million.

  • Nuvation Bio's Notes Payables fell 3332.54% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 3332.54%. This contributed to the annual value of $6.3 million for FY2024, which is N/A changed from last year.
  • Per Nuvation Bio's latest filing, its Notes Payables stood at $5.6 million for Q3 2025, which was down 3332.54% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Notes Payables registered a high of $11.6 million during Q2 2024, and its lowest value of $5.6 million during Q2 2025.